Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-08-24
1999-10-26
Mach, D M
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514313, 546157, C07D21516, A01N 4342
Patent
active
059729619
ABSTRACT:
The present invention provides novel 4-aryl-3-aminoquinolin-2-one derivatives having the general formula ##STR1## wherein R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as defined herein, or a non-toxic pharmaceutically acceptable salt thereof which are modulators of the large conductance calcium-activated K.sup.+ channels and are useful in the treatment of disorders which are responsive to the opening of the potassium channels.
REFERENCES:
patent: 3202661 (1965-08-01), Brust et al.
patent: 5200422 (1993-04-01), Olesen et al.
patent: 5565472 (1996-10-01), Hamanaka
patent: 5565483 (1996-10-01), Hewawasam et al.
Ahmed, F. et al., "Some Features of the Spasmogenic Actions of Acetylcholine and Histamine in Guinea-Pig Isolated Trachealis", Br. J. Pharmacol., 83, pp. 227-233 (1984).
Baro, I. and Escande, D., "A Ca.sup.2+ -activated K.sup.+ Current in Guinea-pig Atrial Myocytes", Pflugers Archiv., 414(Suppl. 1), pp. S168-S-170 (1989).
Cook, N.S., "The Pharmacology of Potassium Channels and Their Therapeutic Potential", Trends in Pharmacol. Sciences, 9, pp. 21-28 (Jan., 1988).
Koh, D-S., et al., "Effect of the Flavoid Phloretin on Ca.sup.2+ -activated K.sup.+ Channels in Myelinated Nerve Fibres of Xenopus Laevis", Neuroscience Lett. 165, pp. 167-170 (1994).
Laurent, F. et al., "Evaluation of the Relaxant Effects of SCA40, A Novel Charybdotoxin-Sensitive Potassium Channel Opener, in Guinea-Pig Trachealis", Br. J. Pharmacol., 108, pp. 622-626 (1993).
Masoud, M. S., et al, "Spectral Studies on Some 2-Quinolones", Spectroscopy Letters, 21(6), pp. 369-383 (1988).
Masoud, M. S., et al., "Solution Equilibria and Structures of Some 2-Quinolone Iron (III), Cobalt (II), Nickel (II) and Copper (II) Complexes", Synth. React. Inorg. Met.-Org. Chem., 17, (8 & 9), pp. 881-899 (1987).
The Merck Index, 11th Edition, p. 1575 (1989).
Mohammed, Y. S., et al, "Synthesis of 4-Substituted-3-hydroxy-2-quinolones and Azines", Pharmazie, 40, pp. 312-314 (1985).
Olesen, S.-P., et al, "Selective Activation of Ca.sup.2+ -dependent K.sup.+ channels by Novel Benzimidazolone", European J. Pharmacol., 251, pp. 53-59 (1994).
Quast, U. and Cook, N. S, "Moving Together: K.sup.+ Channel Openers and ATP-sensitive K.sup.+ Channels", Trends in Pharmacol. Sciences, 10, pp. 431-435 (Nov., 1989).
Singer, J. J. and Walsh, J.V., "Characterization of Calcium-activated Potassium Channels in Single Smooth Muscle Cells Using the Patch-clamp Technique", Pflugers Archiv., 408, pp. 98-111 (1987).
Trivedi, S., et al., "Calcium Dependent K-Channels In Guinea Pig and Human Urinary Bladder", Biochemical and Biophysical Research Communications, 213, No. 2, pp. 404-409 (Aug., 1995).
Walser, A., et al, "Cyclization Products Derived from o-Benzoyl Malonanilates", J. Org. Chem., 38, (3), pp. 449-456 (1973).
Hewawasam Piyasena
Starrett, Jr. John E.
Swartz Stephen G.
Algieri Aldo A.
Bristol--Myers Squibb Company
Mach D M
LandOfFree
4-aryl-3-aminoquinoline-2-one derivatives as potassium channel m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764963